Summary: Non-esterified cholesterol was determined enzymatically with the cholesterol oxidase-peroxidase reaction using phenol and 4-aminophenazone as chromogens. This assay was done in the supernatant containing the lipoprotein-X. Other serum lipoproteins were removed by precipitation with heparin and zinc acetate followed by centrifugation. No standardization was required, the lipoprotein-X concentration being calculated with the use of the constant.
Introduction
Lipoprotein-X, a specific marker of cholestasis, was hitherto determined by rather complicated procedures. Its quantitative determination may be helpful, e. g. for differentiating between the intra-and extrahepatic cholestasis in infants receiving cholestyramine, (Campbell, D. P. & Williams, R. G., cf. in 1. c. (1)). The turbidimetric method ofGoverde et al. (2) utilizes antiserum to remove the interacting lipoproteins. The turbidimetric method without antibody described in the previous paper (3) suffers from the general disadvantages of measuring turbidity. It requires standardization with lipoprotein-X solution of a known concentration. The preparation of lipoprotein-X concentrate, although much simplified (3), includes collecting strongly lipoproteinOC positive sera s its source. These complications have been overcome by measuring npnresterified cholesterol by the specific enzymatic test (4) . The non*esterified cholesterol represents one of the major lipoprotein-X constituents (224 g/kg) (Seidel, D., et al., cf. in 1. e. (1)). The lipoprotein-X consists of the subfractions lipoprotein-Xj, lipQprptein-X 2 and lipoprotein-X 3 , the cholesterol contents of which differ slightly (Patsch, J. R. et al., of. in 1. c. (1)); This does not affect seriously the lipoprotein-X determinations based on its cholesterol content. The lipoproteins other than lippprotein-X were removed from the examined serum using the prnciple devised by Sobeslavsky and modified in the method previously described (3).
Materials and Methods
Spekol 10 (Carl Zeiss, Jena GDR) with plastic cuvettes (Sarstedt, Numbrecht-Rommelsdorf, FRG), light path 1 cm, width 0.4 cm, height 3.1 cm (cut from the original height of 4.5 cm) were used for measurements. From the commercial kit "Cholesterin, Boehringer Mannheim CHOD-PAP Methode, No. 172626" only the solutions 1 and 2 (the chromogens) were used to prepare the reagent: 1 volume of the solution 1 with 1 volume of the solution 2 were mixed and for each ml of this mixture about 8 μΐ of cholesterol oxidase (EC 1.1.3.6) suspension (25 kU/1, Boehringer Mannheim, No. 126934), followed by 8 μΐ of an aqueous solution of horse radish peroxidase (EC 1.11.1.7) (Sigma Chem. Co., Type I) 3 g/1, and 10 μΐ of aqueous 0.12 mol/1 EDTA. The examined serum (150 μΐ) was diluted with 150 μΐ of an aqueous solution containing 1 g/1 heparin and 0.15 mol/1 NaCl. After mixing 30 μΐ of aqueous 0.26 mol/1 zinc acetate solution were added, mixed well and incubated in a water bath for about l h at 40 °C. Then the tube was cooled to room temperature (23-25 °C) in a water bath for 5 min and centrifuged at about 3000 g for 15 min. To 100 μΐ of the supernatant 500 μΐ of the cholesterol reagent were added, incubated at 38 °C for 15-20 min and the red colour was read at 500 nm against a blank consisting of 100 μΐ of 0.15 mol/1 NaCl incubated with 500 μΐ of the reagent. When the colour was too deep to be measured only 50 or 25 μΐ of the supernatant diluted with 50 or 75 μΐ of 0.15 mol/1 NaCl were used and 0340-076X/81/0019-0155502.00 © by Walter de Gruyter & Co. · Berlin · New York ι ι the results were multiplied by 2 or 4. The resulting absorbance was multiplied by the factor 3.405 to obtain the serum lipoprotein-X concentration in g/1. This factor was derived from the data (absorbance χ 5.85) given in the directions (4), taking in account the real volume of serum (45.5 μ\) applied to the enzymatic colour reaction, the dilution factor of the reagent (-), i. e. 100 μΐ of the supernatant instead of 5 μΐ sample added to 500 μΐ of the enzymatic reagent, and the non-esterified cholesterol content of lipoprotein-X (224 g/kg).
The removal of lipoproteins other than lipoprotein-X was checked by submitting the supernatant obtained after heparinZn 2+ precipitation to agar gel electrophoresis and detection with Ca 2 *-dextran sulfate. No turbidity was observed on the anodic side of the well, which indicates that anodically migrating lipoproteins are virtually absent. (This check is not included into the routine procedure.) The same test was done with the lipoprotein-X concentrate (3) used for the construction of a calibration curve ( fig. 1) . No anodically migrating lipoproteins were detected. In this sample of lipoprotein-X concentrate the contents of phospholipids (14.6 g/1), of non-esterified cholesterol (5.05 g/1), and of total cholesterol (5.75 g/1) indicated an lipoprotein-X concentration of 22 g/1.
Results and Discussion
Pooled sera from normal persons and the sera from various disease states were investigated by this method and the results were compared with those obtained by turbidimetry (3) and agar gel electrophoresis (table 1) . The lipoprotein-X positive sera were analyzed several times (n) within one run and statistically evaluated (5). The variation coefficients (CV) were in the range of 0.61 and 4.87, the highest CV being with the lowest lipoprotein-X levels. Two samples of sera so that the inhibitory concentration in the supernatant was not attained even at a bilirubin concentration of 513 jumol/1 in the serum containing 2.34 g/lipoprotein-X. Higher lipoprotein-X concentration caused higher bilirubin in the supernatant, while serum without lipoprotein-X yielded a supernatant with no appreciable bilirubin. Since the determination of higher lipoprotein-X levels required dilution of the supernatant, the inhibitory bilirubin concentration was never reached. Ascorbate did not inhibit when added to the analyzed serum up to a concentration of 227 μπιοΐ/ΐ. Such high serum ascorbate was not reported even after a large ascorbic acid dose (6) . Sodium azide and p-hydroxymercuribenzoate did not inhibit in the concentrations tested (i. e. 52.4 and 3.32 mmol/1, resp.). The method is simple, it allows the lipoprotein-X to be determined even at very low serum levels not measurable by either of the previously described methods (1) and it eliminates the need to prepare the lipoprotein-X solution of a known concentration (3) . The present method, like the immunoprecipitation method, is not applicable to very strongly chylous sera of milky appearance (2), e. g., a case with 12.6 mmol/1 triglycerides and 6.92 mmol/1 cholesterol gave a slight false absorbancy of 0.035 (which would correspond to 0.12 g/1 lipoprotein-X). This was caused by excessively increased non-lipoprotein-X lipoproteins which were not completely precipitated with heparinZn 2+ .
